INS and type 2 diabetes mellitus: These proinflammatory mediators can directly or indirectly affect inflammation-related pathways, such as the JNK and IKKβ/NF-κB pathways, and also disrupt insulin signaling, eventually leading to systemic insulin resistance and the subsequent development of T2DM (102).